Loading...
Loading...
India's plasma imports from SOUTH KOREA total $86.1K across 22 shipments from 5 foreign suppliers. GREEN CROSS CORPORATION leads with $78.0K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include PLASMAGEN BIOSCIENCES PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for plasma โ a diversified sourcing base with multiple active suppliers from SOUTH KOREA.

GREEN CROSS CORPORATION is the leading Plasma supplier from SOUTH KOREA to India, with import value of $78.0K across 1 shipments. The top 5 suppliers โ GREEN CROSS CORPORATION, RESEARCH MENTOR CO.,LTD., VETALL LABORATORIES, SAPIENS BIO INC., M S SAPIENSBIO INC โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | GREEN CROSS CORPORATION | $78.0K | 1 | 90.6% |
| 2 |
| RESEARCH MENTOR CO.,LTD. |
| $7.7K |
| 18 |
| 8.9% |
| 3 | VETALL LABORATORIES | $285 | 1 | 0.3% |
| 4 | SAPIENS BIO INC. | $85 | 1 | 0.1% |
| 5 | M S SAPIENSBIO INC | $59 | 1 | 0.1% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PLASMAGEN BIOSCIENCES PRIVATE LIMITED | $78.0K | 1 | 90.6% |
| 2 | SYNCORP HEALTH PRIVATE LIMITED | $7.7K | 18 | 8.9% |
| 3 | UBIO BIOTECHNOLOGY SYSTEMS PRIVATE LIMITED | $285 | 1 | 0.3% |
| 4 | ADGYL LIFESCIENCES PRIVATE LIMITED | $143 | 2 | 0.2% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Plasma suppliers from SOUTH KOREA to India include GREEN CROSS CORPORATION, RESEARCH MENTOR CO.,LTD., VETALL LABORATORIES. The leading supplier is GREEN CROSS CORPORATION with import value of $78.0K USD across 1 shipments. India imported Plasma worth $86.1K USD from SOUTH KOREA in total across 22 shipments.
India imported Plasma worth $86.1K USD from SOUTH KOREA across 22 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Plasma sourced from SOUTH KOREA include PLASMAGEN BIOSCIENCES PRIVATE LIMITED, SYNCORP HEALTH PRIVATE LIMITED, UBIO BIOTECHNOLOGY SYSTEMS PRIVATE LIMITED. The largest buyer is PLASMAGEN BIOSCIENCES PRIVATE LIMITED with $78.0K in imports across 1 shipments.
The total value of Plasma imports from SOUTH KOREA to India is $86.1K USD, across 22 shipments and 5 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
22 Verified Shipments
5 suppliers, 4 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists